WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996005851) USE OF TASTELESS, HYDROLYSED COLLAGEN AND AGENT CONTAINING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/005851    International Application No.:    PCT/EP1995/003304
Publication Date: 29.02.1996 International Filing Date: 19.08.1995
Chapter 2 Demand Filed:    01.02.1996    
IPC:
A61K 38/01 (2006.01), A61K 38/23 (2006.01)
Applicants: DGF STOESS AG [DE/DE]; Postfach 12 53, D-69402 Eberbach (DE) (For All Designated States Except US).
MILAN, Adam [CZ/CZ]; (CZ) (For US Only).
EGGERSGLÜSS, Bernd [DE/DE]; (DE) (For US Only).
BRÄUMER, Klaus [DE/DE]; (DE) (For US Only).
SCHRIEBER, Reinhard [DE/DE]; (DE) (For US Only)
Inventors: MILAN, Adam; (CZ).
EGGERSGLÜSS, Bernd; (DE).
BRÄUMER, Klaus; (DE).
SCHRIEBER, Reinhard; (DE)
Agent: WERNER, Hans-Karsten; Deichmannhaus am Hauptbahnhof, D-50667 Köln (DE)
Priority Data:
P 44 29 842.0 23.08.1994 DE
Title (DE) VERWENDUNG VON GESCHMACKSNEUTRALEM, HYDROLYSIERTEM KOLLAGEN UND MITTEL ENTHALTEND DASSELBE
(EN) USE OF TASTELESS, HYDROLYSED COLLAGEN AND AGENT CONTAINING THE SAME
(FR) UTILISATION DE COLLAGENE HYDROLYSE, SANS GOUT, ET SUBSTANCE CONTENANT LEDIT COLLAGENE
Abstract: front page image
(DE)Geschmacksneutrales hydrolysiertes Kollagen aus Gelatine, Gelatine oder tierischen kollagenen Bindegewebe mit einem mittleren Molekulargewicht von 1 bis 40 kD zur Herstellung von Mitteln zur Behandlung von Osteoporose. Es kann kombiniert werden mit herkömmlichen Mitteln zur Bekämpfung der Osteoporose wie Calcitonin, Calciumsalzen und/oder Progesteron.
(EN)The invention concerns the use of tasteless, hydrolysed collagen from gelatine, of gelatine or collagenic animal connective tissue with an average molecular weight of 1 to 40 kD for preparing osteoporosis treatment agents. It can be combined with conventional agents for combatting osteoporosis, such as calcitonin, calcium salts and/or progesterone.
(FR)L'invention concerne l'utilisation de collagène hydrolysé sans goût issu de la gélatine, de gélatine ou de tissu conjonctif animal collagénique, présentant un poids moléculaire moyen compris entre 1 et 40 kD, pour la fabrication de substances destinées au traitement de l'ostéoporose. Ces substances peuvent être combinées à des substances classiques de lutte contre l'ostéoporose telles que la calcitonine, les sels de calcium et/ou la progestérone.
Designated States: AU, CA, FI, JP, NO, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: German (DE)
Filing Language: German (DE)